Cite
MLA Citation
Tanuja Narayansamy Gengiah et al.. “CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women.” BMJ open, vol. 12, no. 1, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100148628899.0x000023